SEC 13F Intelligence

Haven Capital Group, Inc. / ABBV

Haven Capital Group, Inc.’s Abbvie Inc Position

Does Haven Capital Group, Inc. own Abbvie Inc (ABBV)? Yes — 21.8K shares worth $5M (+4.41% of its 13F portfolio) as of Q1 2026, up from 21.6K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
21.8K
% of Portfolio
+4.41%
Quarters Held
6
currently held

Position History ABBV

Reported value by quarter
Q4 ’24: $4MQ4 ’24Q1 ’25: $5MQ1 ’25Q2 ’25: $4MQ2 ’25Q3 ’25: $5MQ3 ’25Q4 ’25: $5MQ4 ’25Q1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202621.8K$5M+4.41%
Q4 202521.6K$5M+4.63%
Q3 202521.6K$5M+4.45%
Q2 202521.8K$4M+3.57%
Q1 202522.4K$5M+5.17%
Q4 202423.0K$4M+3.85%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Haven Capital Group, Inc.’s full portfolio or all institutional holders of ABBV.